Circumventing qPCR inhibition to amplify miRNAs in plasma

Biomarker Research

Volumn 2, Issue 1, 2014, Pages

  Plieskatt, Jordan L ^a   Feng, Yanjun ^a   Rinaldi, Gabriel ^a   Mulvenna, Jason P ^b,c   Bethony, Jeffrey M ^a   Brindley, Paul J ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Anti coagulant; Bacteroides heparinase I; Biomarker; Eliminase; Heparin; Heparinase; Interference; miRNA; Plasma; qPCR; Reverse transcriptase

Indexed keywords

HEPARIN LYASE; MICRORNA; RNA DIRECTED DNA POLYMERASE;

ARTICLE; BACTEROIDES; BILE DUCT CARCINOMA; CONTROLLED STUDY; HUMAN; NONHUMAN; PHLEBOTOMY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA DEGRADATION; RNA ISOLATION; SENSITIVITY ANALYSIS; SEROLOGY;

BACTEROIDES; PEDOBACTER HEPARINUS;

EID: 84928959173     PISSN: None     EISSN: 20507771     Source Type: Journal    
DOI: 10.1186/2050-7771-2-13     Document Type: Article

References (20)

1. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006, 6:857-866. 10.1038/nrc1997, 17060945.
2. Sun W, Li YSJ, Huang HD, Shyy JYJ, Chien S. microRNA: A master regulator of cellular processes for bioengineering systems. Ann Rev Biomed Eng 2010, 12:1-27.
3. He L, Hannon GL. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004, 5:522-531. 10.1038/nrg1379, 15211354.
4. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297. 10.1016/S0092-8674(04)00045-5, 14744438.
5. Git A, Dvinge H, Salmon-Divon M, Osborne M, Kutter C, Hadfield J, Bertone B, Caldas C. Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. RNA 2010, 16:991-1006. 10.1261/rna.1947110, 2856892, 20360395.
6. Pigati L, Yaddanapudi SC, Iyengar R, Kim DJ, Hearn SA, Danforth D, Hastings ML, Duelli DM. Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One 2010, 5:e13515. 10.1371/journal.pone.0013515, 2958125, 20976003.
7. Pu XX, Huang GL, Guo HQ, Guo CC, Li H, Ye S, Ling S, Jiang L, Tian Y, Lin TY. Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J Gastroenterol Hepatol 2010, 25:1674-1680. 10.1111/j.1440-1746.2010.06417.x, 20880178.
8. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2009, 112:55-59. 10.1016/j.ygyno.2008.08.036, 18954897.
9. Mostert B, Sieuwerts AM, Martens JW, Sleijfer S. Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients. Exp Rev Mol Diagn 2011, 11:259-275.
10. Ginzinger DG. Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol 2002, 30:503-512. 10.1016/S0301-472X(02)00806-8, 12063017.
11. Siev M, Yu X, Prados_Rosales R, Martiniuk FT, Achkar JM. Correlation between serum and plasma antibody titers to mycobacterial antigens. Clin Vaccine Immunol 2011, 18:173-175. 10.1128/CVI.00325-10, 3019788, 21047999.
12. Johnson ML, Navanukraw C, Grazul-Bilska AT, Reynolds LP, Redmer DA. Heparinase treatment of RNA before quantitative real-time RT-PCR. Bio Tech 2003, 35:1140-1142. 1144.
13. Bai X, Fischer S, Keshavjee S, Liu M. Heparin interference with reverse transcriptase polymerase chain reaction of RNA extracted from lungs after ischemia-reperfusion. Transpl Int 2000, 13:146-150. 10.1111/j.1432-2277.2000.tb01055.x, 10836652.
14. Garcia ME, Blanco JL, Caballero J, Gargallo-Viola D. Anticoagulants interfere with PCR used to diagnose invasive aspergillosis. J Clin Microbiol 2002, 40:1567-1568. 10.1128/JCM.40.4.1567-1568.2002, 140326, 11923400.
15. Sripa B, Brindley PJ, Mulvenna J, Laha T, Smout MJ, Mairiang E, Bethony JM, Loukas A. The tumorigenic liver fluke Opisthorchis viverrini -- multiple pathways to cancer. Trends Parasitol 2012, 28:395-407. 10.1016/j.pt.2012.07.006, 3682777, 22947297.
16. Lim LP, Lau NC, Weinstein EG, Abdelhakim A, Yekta S, Rhoades MW, Burge CB, Bartel DP. The microRNAs of Caenorhabditis elegans. Gen Dev 2003, 17:991-1008.
17. Plieskatt JL, Rinaldi G, Feng Y, Levine PH, Easley S, Martinez E, Hashmi S, Sadeghi N, Brindley PJ, Bethony JM, Mulvenna JP. Methods and matrices: approaches to identifying miRNAs for Nasopharyngeal carcinoma. J Trans Med 2014, 12:3.
18. Merchant ZM, Kim YS, Rice KG, Linhardt RJ. Structure of heparin-derived tetrasaccharides. Biochem J 1985, 229:369-377. 1145069, 4038274.
19. Yamada S, Murakami T, Tsuda H, Yoshida K, Sugahara K. Isolation of the porcine heparin tetrasaccharides with glucuronate 2-O-sulfate. Heparinase cleaves glucuronate 2-O-sulfate-containing disaccharides in highly sulfated blocks in heparin. J Biol Chem 1995, 270:8696-8705.
20. Plieskatt JL, Rinaldi G, Feng Y, Peng J, Yonglitthipagon P, Easley S, Laha T, Pairojkul C, Bhudhisawasdi V, Sripa B, Brindley PJ, Mulvenna JP, Bethony JM. Distinct miRNA signatures associate with subtypes of cholangiocarcinoma from infection with the tumorigenic liver fluke Opisthorchis viverrini. J Hepatol 2014, doi:10.1016/j.jhep.2014.05.035.